Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.00
Bid: 31.00
Ask: 33.00
Change: -0.50 (-1.54%)
Spread: 2.00 (6.452%)
Open: 32.50
High: 32.50
Low: 32.00
Prev. Close: 32.50
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and COVID-19 Update

28 Apr 2020 07:00

RNS Number : 0467L
Panoply Holdings PLC (The)
28 April 2020
 

This announcement contains inside information

28 April 2020

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Trading and COVID-19 Update

 

The Panoply Holdings PLC, a digitally native technology services group, today announces a trading update for the year ended 31 March 2020 (FY20).

 

The Board expects to report Revenue and Adjusted EBITDA performance in line with market expectations. Revenues in the second half increased to approximately £18m (H1: £13m), driven by new client wins along with Brexit and election related stability. On a pro forma basis, including the acquisition of Ameo, revenue for H2 would have been approximately £21.8m.

 

During the year the Group completed two acquisitions in the public services sector: FutureGov, a leader in digital service design; and Ameo, a consultancy specialising in delivering business change. These acquisitions, alongside developments made across the Group's existing business, have significantly strengthened The Panoply's public sector offering, which now represents approximately 70% of the Group's revenues on a pro forma basis (FY19: 56%). With the Group able to collaborate effectively across its constituent companies, The Panoply represents a compelling end-to-end offering for organisations in this sector looking to embrace digital transformation at pace.

 

Financial position

 

As at 31 March 2020 the Group's balance sheet had retained cash reserves of approximately £4.5m and a net debt position of £0.5m. As of 24 April the Group held £6.2m of cash and cash generation is expected to remain strong as trading profits from the final quarter are realised. Following the year end the Group has agreed a £1.5m overdraft facility with HSBC and is in early discussions about extending the Revolving Credit Facility in order to provide sufficient financial flexibility should it be required for further acquisitions or otherwise.

 

Pleasingly, the acquisitions made by the Group to date have traded in line with expectations and so it is anticipated that further consideration will become payable on publication of the full year result. This is expected to be in line with previous guidance of approximately £17m. Any consideration will be satisfied by the issue of new shares in The Panoply based on the share price at that time and in accordance with the pre-announced formulas subject always to a minimum floor of 74p.

 

COVID-19

 

The Group's top priority is the health and safety of its team, clients and the communities in which it operates in and it implemented remote working ahead of government guidance. As an agile technology services group, The Panoply has been able to continue operating effectively during this period and its teams are continuing to fully service clients. At present, the Group has not seen a net negative impact on revenue and staff utilisation remains greater than 70%, which is in line with previous periods.

 

The Group is proud to be working with a number of clients on the COVID-19 emergency response. FutureGov have been working with Camden Council, having together designed and built an open source directory of service tool, "Beacon", which helps the council and local public service partners understand the needs of vulnerable residents, matching them to the relevant support. FutureGov and Notbinary have built both ventilator and PPE 'dashboards' in order to help manage the effective supply of these crucial products, whilst Notbinary has created a system with the Competition and Markets Authority via the Department for Business, Energy & Industrial Strategy which allows businesses to be held to account for unfair behaviour during the crisis.

 

Human+ & FutureGov along with other industry partners are proud to be working with NHSx to assist NHS efforts to support vulnerable people during COVID-19. The Group will be supporting the development and execution of user-centred design, Intelligent Automation and Artificial Intelligence. This includes user research, robotic process automation (RPA) and service design support to help evaluate and design remote care and digital mental health solutions, as well as data coalition and automation opportunities, across the NHS.

 

The Group continues to closely monitor and manage its costs throughout this time of increased uncertainty in order to be prudent, with a hiring freeze in place and careful management of any discretionary spending. The Group has also introduced a number of additional short-term data points to the range of KPIs monitored to provide greater visibility throughout the Group. To date the Group has not furloughed any staff and in the UK, where there are very small pockets of underutilised staff, they have been encouraged to volunteer in their communities on full pay.

 

Outlook

 

There are several factors which should reassure the Group's employees and shareholders that the business has the resilience to be ready to capitalise on opportunities when they emerge. The majority of revenues are generated from existing client relationships and the Group continues to win business currently scheduled for completion in the balance of the year.

 

The Group is therefore confident in its decision to continue making investments in the business in FY2021 and that its growth strategy over the longer term will continue to see consistent investment in innovation and through further acquisitions to support its growth in the following years. In line with its entrepreneurial values, the Group will continue to invest in business opportunities developed by its talented and innovative employees. The Board believes pursuing these opportunities is in the best interests of all stakeholders and the right strategy to ensure the Group's long term, sustainable success.

 

In the first half of FY2021 the Group anticipates revenues to exceed the prior period and for the business to remain profitable and cash generative. Whilst the increase in public sector work is expected to more than mitigate the softening in demand from clients in other sectors, given the nature of public sector work the Group expects margins to be somewhat lower than previously. Some of the work is being done on an entirely pro bono basis.

 

It is difficult to predict how the developing situation will impact the behaviour of clients and therefore, given the lack of visibility on the period beyond H1, the Group is suspending future guidance. Notwithstanding this, the Group is confident that it will remain cash generative and EBITDA profitable for FY21. The Board recognises the importance of dividend income to shareholders but, in light of the current uncertainty, is not intending to pay a dividend for FY20 and is currently reviewing when to commence dividend payments.

 

Neal Gandhi, CEO of The Panoply, commented:

 

"I am pleased with the progress that we made last year and honoured to now be supporting a number of public sector businesses, including NHSx, tackling the COVID-19 pandemic. Notwithstanding the challenging macro-economic environment we currently face, we are well structured to continue to provide our services to clients, and believe that this situation will ultimately bring greater focus to the benefits of digital transformation and accelerate demand for our services further."

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44(0)203 405 0205

 

The person responsible for making this announcement is Oliver Rigby, CFO.

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

More information is available at www.thepanoply.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTZZGZDGNDGGZZ
Date   Source Headline
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.